MannKind Corp. (MNKD)

5.66 +0.04 (+0.71%) USD  |  NASDAQ  |  Jan 06, 15:46
More

MannKind Research and Development Expense (Annual): 45.89M for Dec. 31, 2024

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for MNKD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Moderna, Inc. 4.354B
Vertex Pharmaceuticals, Inc. 3.630B
Ocugen, Inc. 30.16M
Protagonist Therapeutics, Inc. 138.13M
Ovid Therapeutics, Inc. 36.37M